Disease Management Conference 2008


	Organised by



	Supporting Organisations



	Mike BAINBRIDGE Mike has been a leading figure in Clinical Informatics for 25 years working both for Government and Industry. He has designed and brought to market Clinical Computer Systems for General Practitioners. He was instrumental in the 2003 negotiation of the IT elements of the current General Practitioner Contracts in the UK. He currently leads the Clinical Architecture, Assistive Technology and Clinical Decision Support teams at NHS Connecting for Health (NHS CFH). These teams are delivering innovations in hardware design, clinical interface design and interfaces for the both professionals and citizens to the electronic medical record. As a former General Medical Practitioner and medical informatics expert, Mike brings a unique insight to the field. Mike previously held the position of chairman of the Primary Health Care Specialist Group of the British Computer Society. He currently sits on the Editorial Board for the Journal of Informatics in Primary Care. Through his work for the NHS in England, Mike continues to advocate both patient safety and clinical utility and to demonstrate its relevance and use in an international forum. He was voted 'UK Health ICT champion' in November 2007

	Marco BONOLLO Dr Marco Bonollo graduated from Monash University with Honours in 1990. He completed his basic physician training at the Royal Melbourne Hospital and Middlesex Hospital, London. Subsequently, he undertook advanced training in renal medicine under Prof. Gavin Becker at the Royal Melbourne Hospital and Prof. Napier Thomson at The Alfred. In 2001, he was asked to lead the re-establishment of an ambulatory general medical clinic at Melbourne’s Alfred Hospital. He re-defined the service as a “Disease Management” (DM) program targeted at patients with multiple medical problems who are frequently admitted to hospital in an effort to coordinate their care. The Disease Management Unit (DMU), as Australia’s largest DM service, manages over five hundred “Frequent-Flyer” patients, with reductions in both hospital admissions and emergency presentations by over 50% and total bed occupancy by over 75%. In 2004, he helped found the Australian Disease Management Association as a forum for DM activities across the Australian healthcare sector, and, is currently the Chair of its Advisory Committee. His expertise and efforts in promoting DM have been recognized by the Disease Management Association of America (DMAA) as an invited speaker to their Conference in 2003, and, a major “Pioneer” award. His current appointments are as Head, Disease Management Unit (DMU) Bayside Health, Nephrologist in the Dept. of Renal Medicine and General Physician in the Professorial General Medical Unit at Melbourne’s Alfred Hospital. He is Secretary of the The Alfred Senior Medical Staff and member of the Medical Advisory Committee at Cotham Private Hospital (Healthscope). In addition to DM, his clinical interests are the prevention & management of acute renal failure and ortho-geriatric medicine. His enthusiasm for medical education was inspired by his mentor, the late Prof. E. F. Glasgow. As a Lecturer at Monash University Medical School (Alfred Hospital), he convenes 3rd year undergraduate medicine teaching and lectures in nephrology. He is a Clinical Examiner for the Faculty of Medicine, Monash University and the Royal Australasian College of Physicians.

	Sandra DELON SANDRA DELON, PhD, MPsych is the Director of Chronic Disease Management in the Calgary Health Region. She is responsible for developing a regional strategic and implementation plan for chronic disease management across the continuum of care. Sandra has worked with the Calgary Health Region for almost 10 years in a research and evaluation capacity. In addition to health care Sandra has worked in strategic planning in a variety of sectors including management consulting with KPMG in Australia, financial services with American Express in New York and marketing with J. Walter Thompson Advertising Agency in New York. She has been an adjunct professor at the University of South Australia, New York University and currently holds this role with the University of Calgary in the Faculty of Medicine. Sandra obtained a Master of Psychology in Adelaide, Australia and a PhD at the University of Alberta, Edmonton.

	Trisha GREENHALGH Professor Trisha Greenhalgh is a non-principal GP in north London and Professor of Primary Health Care at University College London, where she has worked since 1986. She also holds a Consultant post in Primary Health Care at Barnet Primary Care Trust. Her diverse research interests fall into three main categories: (a) complex innovation in healthcare, especially the introduction and assimilation of ‘networked’ electronic health records; (b) service development for chronic disease management, with a particular focus on the provision of culturally congruent services for diabetes; and (c) the use of narrative methods in health services research, especially in the realm of audit and quality improvement. Prof Greenhalgh is Programme Director of the Masters in International Primary Health Care at UCL (which currently offers 20 free scholarships annually to students from developing countries) and of the Dick Whittington Project (which welcomes 40 academically able teenagers from socio-economically deprived backgrounds annually to a pre-medicine summer school). She has published over 90 papers in peer reviewed journals, is the author of 7 academic textbooks, and was awarded the OBE for Services to Medicine in 2001.

	Alejandro (Alex) JADAD Dr. Jadad’s mission is to help improve health and wellness for all, thorough information and communication technologies (ICTs). His research and innovation work focuses on virtual tools to support the encounter between the public and the health system (with emphasis on self-management of chronic conditions); interactive tools to promote knowledge translation and mentorship of health professionals and the public; and online resources to support social networks, to respond to major public health threats (e.g., chronic conditions, pandemics), to support international collaboration, and to enable the public (particularly young people) to shape the health system and society. Born and educated in Colombia, he obtained his medical degree in 1986, specializing in anesthesiology. By the time he was 20 years of age and still a medical student, he became a leading medical expert on cocaine in Colombia and an internationally sought after speaker. In 1990 he joined the University of Oxford (Balliol College), where he became one of the first physicians in the world with a doctorate in health knowledge synthesis. He developed new methods to distill high-quality healthrelated information and to build specialized bibliographic databases to support health-related decisions. He led the development of the most widely used tool to assess the quality of clinical trials (‘the Jadad scale’), now used throughout the world. His work helped fuel the development of the Cochrane Collaboration, a global network of individuals who are synthesizing over 500,000 clinical trials in all areas of health. In 1995, he moved to Canada and joined McMaster University, where he was Chief of the Health Information Research Unit; Director of the McMaster Evidence-based Practice Centre; Co-Director of the Canadian Cochrane Network and Centre; Associate Medical Director of the Program in Evidencebased Care for Cancer Care Ontario and Professor in the Department of Clinical Epidemiology & Biostatistics. In 2000, Alex moved to Toronto, where he led the creation of the Centre for Global eHealth Innovation,a setting designed as a simulator of the future, to study and optimize the use of ICTs before their widespread introduction into the health system and society at large. He is also spearheading the development of the Global eHealth and eWellness Network Initiative (GENI, pronounced as “genie”), a unique group of individuals, organizations, tools and facilities working in harmony to promote research, development, education, policy, funding, recognition and commercialization activities related to the uses of ICTs to promote optimal levels of health and wellness, worldwide. He leads the People, Health equity and Innovation (PHI) Group, which focuses on efforts to level the playing field for disadvantaged members of society, with emphasis on youth leadership development,supportive care (for people with chronic conditions, terminal illnesses or advanced age) and multicultural issues. Dr. Jadad was the founding President of the Spanish eHealth Foundation (he is now President Emeritus), which enabled the creation of the Spanish eHealth Network and Revista eSalud, the leading journal and portal in the Hispanic world focused on eHealth [www.revistaesalud]. In 2005, he was invited by the World Health Organization to act as the representative for the American continent, sitting as a member of its Global Observatory for eHealth’s Strategic Advisory Group of Experts (SAGE). He is now the Chair of the Board of the Foundation that oversees the development of the Centre for Innovation on Human Well-being, a simulator of the future of society, which is being built in Malaga, Spain, with federal and regional funds. Dr. Jadad has received numerous awards, including a 'National Health Research Scholars Award', by Health Canada (1997), one of 'Canada's Top 40 Under 40' awards (1998), a 'Premier's Research Excellence Award' (1999), the New Pioneers Award in Science and Technology (2002). In 2001 and 2002, he was featured by Time Magazine as one of the new Canadians who will shape the country in the 21st century, and as one of the leading medical researchers in the country. In 2004, he received the Canadian Latin Achievement Award, as one of the people who have made important contributions to the relationship between Canada and the Hispanic world. In 2005, he was selected by the Top 40 Under 40 alumni as one of “The Best of the Best” for achievements in Health and Science, and by his peers in Colombia as the scientist who probably has had the greatest impact in the country’s history. In 2006, he received the Distinguished Lecturer Award from Health Canada’s Chief Scientist for his contributions to health and the health system. In 2007, he was invited by the British Medical Journal to author the article on the impact of computers on human health, which was published in a commemorative issue that featured the top 15 medical breakthroughs since 1840, when the journal was published for the first time. In 2007, Dr. Jadad became a Fellow of the Canadian Academy of Health Sciences, and was selected by media and community leaders as one of Canada’s “10 most influential Hispanic Canadians”.

	Anil KAPUR Dr Anil Kapur is Managing Director World Diabetes Foundation. He has been associated with the foundation since its inception, previously serving on its Board as the Vice Chairman. He has previously, worked in several capacities in Novo Nordisk. Initially as managing director Novo Nordisk India, later as Vice President Novo Nordisk Regional office India and Vice President Novo Nordisk Corporate Stakeholder Relations – Asia. He setup and served as managing trustee of the Novo Nordisk Education Foundation in India. Dr Kapur has specialized in internal medicine. He has written books on diabetes both for medical professionals and lay people and published more than sixty papers in the areas of internal medicine, clinical pharmacology and diabetes, in Indian and international journals. Dr Kapur has coordinated several large studies – DiabCare Asia India study, Cost of Diabetes Care in India and the National Urban Diabetes Survey – and has developed a nutritional software package called NINA. He has co-ordinated several international meetings on diabetes and given numerous lectures on diabetes, in India and abroad as an invited speaker.

	Gerald KOH Gerald Koh graduated from the National University of Singapore (NUS) with MBBS in 1996, Masters in Medicine in Family Medicine (MMed FM) in 2000 and Graduate Diploma in Geriatric Medicine (GDGM) in 2002. He was entered into the College of Family Physicians of Singapore (CFPS) as a Fellow in 2003. He worked in Ang Mo Kio Community Hospital from 2000 to 2004, firstly as a medical office and later as a Registrar. He was a Consultant Family Physician at Raffles Medical Group from 2004 before he joined the Community, Occupational and Family Medicine Department of the Yong Loo Lin School of Medicine (YLLSoM) of the National University of Singapore in 2005 as an Assistant Professor. He is currently both trainer and examiner for GDFM and GDGM, and past Deputy Chief Examiner for the MMed FM exams. He was also awarded an international Merck fellowship to read for a Postgraduate Diploma in Gerontology and Geriatrics under the auspices of the United Nations International Institute on Ageing (UN-INIA) at the European Institute of Gerontology. He has lectured regionally and internationally on geriatrics and gerontology for UN-INIA. His current research interests include geriatric rehabilitation, salivary biomarkers, occupational safety of healthcare workers and medical education.

	Shinya MATSUDA Shinya MATSUDA is Professor of the Department of Preventive Medicine and Community Health at School of Medicine, University of Occupational and Environmental Health, Japan. He is a member of various governmental committees related to health system in Japan. Especially he contributes a lot for development of the Japanese Disease Management System as a chief researcher. Today the DM system developed by his research team is used in the various DM organizations in Japan. He is a vice-president of the Japan Society of Health Support Science that is the most active academic organization of Disease Management in Japan. Annually he produces more than 50 research papers for domestic and international journals. His main current research interests are about health systems, managerial tools for health institution, health information systems.

	Soeren MATTKE Soeren Mattke (MD, University of Munich, Germany; DSc, Harvard School of Public Health, Health Policy) is a Senior Scientist at RAND and an expert in program evaluation and disease management. He recently completed a review of the evidence for the impact of disease management on cost and quality of care for common chronic conditions. He is conducting various projects related to disease management evaluation, such as evaluating the health and productivity management programs of two Fortune 500 companies and developing improved disease management evaluation methods for Mercer Human Resource Consulting, which Mercer would use to advise employer clients on program selection. He serves on the Outcomes Steering Committee of the Disease Management Association of America, which is developing voluntary industry guidelines. Dr. Mattke has recently moderated a seminar on disease management in Singapore and a workshop on disease management evaluation methods for a joint World Economic Forum – World Health Organization meeting in Dalian, China in September 2007. In addition, Dr. Mattke is RAND’s PI on a CMS project to develop medication measures to ensure quality and efficiency under the Part D benefit. He leads an evidence reviews for the gap in asthma care, its impact and the cost and benefit of closing it and a related project to estimate the impact of insufficient pharmacological treatment for asthma on cost and utilization. Prior to coming to RAND, Dr. Mattke was an administrator at the Health Policy Unit of the Organization for Economic Co-operation and Development (OECD), an intergovernmental research organization in Paris, where he directed the Health Care Quality Indicators Project. This project brings together 23 industrialized countries, international organizations, such the World Health Organization and the European Commission, research institutions, like the International Society for Quality in Healthcare and various academic experts in an attempt to develop a system for comparing quality of care internationally at the health systems level. Before that, he worked on quality of care research at Harvard University and Abt Associates, Inc., and as an invasive cardiologist at the University of Munich Medical Center.

	Shigeru OMI Dr Shigeru Omi was born in Tokyo, Japan, in June 1949. In 1967, on a scholarship from the American Field Service, he attended Potsdam High School in New York and graduated in 1968. He studied Law at Keio University in Japan from 1969 to 1971. He obtained his degree in Medicine from Jichi Medical School in 1978. Dr Omi obtained his doctorate in molecular biology of the hepatitis B virus at the Jichi Medical School, Japan, in 1990. Dr Omi has held a wide range of positions in the field of medicine and public health. After graduation from medical school in 1978, he worked as a Medical Officer in the Bureau of Public Health of Tokyo Metropolitan Government. The job included an assignment as the sole medical doctor on remote islands in the Pacific, where he worked under difficult conditions and with limited resources. From this field activity, he proceeded in 1987 to do research on the molecular biology of the hepatitis B virus at the Division of Immunology, Jichi Medical School. During 1989-1990, Dr Omi served as Deputy Director in the Office of Medical Guidance and Inspection, Bureau of Health Insurance, in the Ministry of Health and Welfare, Japan. Dr Omi joined the World Health Organization (WHO) Western Pacific Regional Office in Manila, Philippines, in 1990 as the Responsible Officer for the Expanded Programme on Immunization (EPI). Dr Omi spearheaded the regional poliomyelitis (polio) eradication initiative in the Western Pacific Region. In 1995, he was promoted to the position of Director of the Division of Communicable Disease Prevention and Control, a post he held until 1998. In 1998-1999, Dr Omi was a professor of public health at Jichi Medical School, Japan. In February 1999, Dr Omi assumed the position of WHO Regional Director for the Western Pacific. It was during Dr Omi's first term as Regional Director that WHO played the lead role in combating the outbreak of severe acute respiratory syndrome (SARS), the first emerging and readily transmissible disease of the 21st century. More than 95% of the SARS cases occurred in the Western Pacific Region. He spearheaded efforts to contain SARS by both tackling the medical issues and addressing the sensitive political concerns inherent in such events. Dr Omi also gave special emphasis to tuberculosis during his first term by making the "Stop TB" programme one of the Region's flagship projects. Dr Omi was elected to a second term as Regional Director in January 2004. A month earlier, the A(H5N1) avian influenza virus was detected in the Region. Much of Dr Omi's work in his second term has focused on working with WHO Member States and various partner agencies to avert a potential influenza pandemic. Dr Omi is married and has two children and two grandchildren.

	Nipit PIRAVEJ Dr.Piravej has been a prominent leader in healthcare management in Thailand since he took up the position of Senior Vice President in-charge of health insurance business at Ayudhya Jardine CMG Life (Ayudhya Allianz C.P. at present) in 1996. With his other roles as President of Center of Healthcare Management Innovation Thailand and Board Member of Thai Medical Informatics Association (TMI), he has initiated series of activities to promote the new concept and application of disease and health management in Thailand through interdisciplinary approach. The alliance he assisted to form among healthcare professionals, health system administrators, the National Health Security Office (NHSO), Health System Research Institute (HSRI) and the Non-communicable Disease Division, Department of Disease Control (DDC), Ministry of Public Health, has brought about the first generation of disease management programs in the country. His recent challenges include the development of some feasible business models for launching disease and health management services to broader consumers in the private healthcare sector.

	Peter SARGIOUS Dr. Peter Sargious is a General Internist and Founding Medical Director of Calgary’s Chronic Disease Management (CDM) Portfolio. He received his MD from the University of Calgary and MPH from Boston University. He was co-chair of the Clinical Advisory Committee for the Western Health Information Collaborative Chronic Disease Infostructure Initiative and, in 2006, received the Department of Medicine’s inaugural Innovation Award for his work in CDM. As a Visiting Scholar at the Royal Melbourne Hospital from October 2006 to March 2007, he is explored the interaction between state and national CDM infrastructures, and developed Health Canada’s synthesis report on chronic disease prevention and management for the Primary Health Care Transition Fund. He is co-chair of Calgary’s Chronic Disease Prevention and Management Conference and is spearheading Canada’s Chronic Care Network.

	Dean SCHILLINGER Dean Schillinger, M.D. is an Associate Professor of Medicine at the University of California San Francisco. He is a practicing primary care physician at San Francisco General Hospital (SFGH), an urban public hospital, where he sees patients, teaches in the primary care residency program, and conducts research. In his administrative capacities, he has directed the Medi-Cal managed care clinic at SFGH, the ambulatory care clinics at SFGH, and has been the Director of Clinical Operations for the Department of Medicine. He is currently the Director of the UCSF Center for Vulnerable Populations, a new research center committed to transforming clinical and public health practice by improving health communication for socially vulnerable people, and the chair of a UCSF-wide translational research committee to expand the scope and quality of implementation and dissemination sciences. Dr. Schillinger has focused his research on healthcare for vulnerable populations. His current work has focused on literacy, health communication, and chronic disease prevention and management. He has carried out a number of studies exploring the impact of limited health literacy on the care of patients with diabetes and heart disease, and was honored with the 2003 Institute for Healthcare Advancement Research Award for this work. He has been awarded grants from NIH, The California Endowment, The Commonwealth Fund, AHRQ, and the California Health Care Foundation to develop and evaluate care management programs tailored to the literacy and language needs of patients with chronic disease, and is a co-investigator for the National Association of Public Health and Hospital Institute’s Diabetes Quality Improvement Consortium. Dr. Schillinger contributed to the 2004 Institute of Medicine Report on Health Literacy, is a section editor for the textbooks Understanding Health Literacy (AMA press) and Caring for Vulnerable and Underserved Populations (Lange series, 2007), and is a former member of the American College of Physician’s Health Communication Advisory Board. He completed an Open Society Institute Advocacy Fellowship working with California Literacy, Inc., a non-profit educational organization that helps people gain literacy skills, to advance the California Health Literacy Initiative. He recently returned from a semester as Visiting Scholar at the University of Chile’s School of Public Health to help develop chronic disease prevention and treatment initiatives. Dr. Schillinger is a father of 9-year old twin boys and a 1-year old girl, and his spouse is a legal services attorney who is managing attorney at Bay Area Legal Aid.

	Barbara STARFIELD Barbara Starfield, a physician and health services researcher, is university distinguished professor and professor of health policy and pediatrics at Johns Hopkins University. She is internationally known for her work in primary care; her books, Primary Care: Concept, Evaluation, and Policy and Primary Care: Balancing Health Needs, Services, and Technology, are widely recognized as the seminal works in the field. She has been instrumental in leading projects to develop important methodological tools, including the Primary Care Assessment Tool, the CHIP tools (to assess adolescent and child health status), and the Johns Hopkins Adjusted Clinical Groups (ACGs) for assessment of diagnosed morbidity burdens reflecting degrees of co-morbidity. She was the co-founder and first president of the International Society for Equity in Health, a scientific organization devoted to furthering knowledge about the determinants of inequity in health and ways to eliminate them. Her work thus focuses on quality of care, health status assessment, primary care evaluation, and equity in health. She is a member of the Institute of Medicine and has been on its governing council, as well as on the National Committee on Vital and Health Statistics, and many other government and professional committees and groups. She has a BA from Swarthmore College, an MD from the State University of New York, Downstate Medical Center, and an MPH from Johns Hopkins University School of Public Health.

	Verena TAN Graduated with Bachelor of Nutrition (Honours I) from King's College London, UK and Masters in Nutrition and Dietetics (merit) from the University of Sydney, Australia, she has been working as a clinical dietitian at Tan Tock Seng Hospital providing dietary advice and medical nutrition therapy since 2005. She is also an Accreditated Practising Dietitian (APD) with the Dietitians Association of Australia. She has a special interests in critical care nutrition as well as Glycemic Index research with its application in the management of chronic diseases.

	Bert VRIJHOEF Bert Vrijhoef holds two permanent appointments. One as associate-professor at the Maastricht University, Faculty of Health, Medicine & Life Sciences, department of Care and Nursing Sciences. In this function he is director of the research program Redesigning Health Care at the School for Public Health and Primary Care (Caphri) and director of the Master program ‘Health Services Innovation’. He combines his appointment at the University with the post of director Research at the department of Integrated care, University Hospital Maastricht. Bert Vrijhoef holds a Master in Health Policy and Management (Health Services) from the Erasmus University Rotterdam, the Netherlands. Between 1996 and 2002 he worked as an associate researcher at the Maastricht University, Faculty of Medicine, where he accomplished his PhD. Topic of his PhD-research was the rearrangement of tasks between physicians and specialist nurses in the care for chronically ill patients. From 2000 on he has been working on several research themes i.e.: a) the measurement of b) the effectiveness of individual elements of integrated care, c) their interaction and d) their shared impact on the quality of chronic care. For this several methods of health services research are applied: RCTs, quasi-experimental designs and literature reviews, the collection of quantitative and qualitative data, and various statistical analyses. Data are collected from patients with chronic diseases like diabetes, asthma, COPD who are treated in primary and/or secondary care settings. He is engaged as principal investigator in studies on for example: the effectiveness of disease management initiatives, the transfer of tasks between physicians and non-physicians (e.g. nurse practitioner), the role of the diabetes nurse in Europe and the cost-effectiveness of home telemonitoring. His research is referred to in national governmental reports. As an (co)author he has written over 50 (inter)national scientific papers. Bert Vrijhoef holds several additional functions, including advisor of the International Disease Management Alliance (IDMA), member of the committee Standard Cardiovascular Risk Profile, chair of the scientific committee of the Dutch Association of Diabetes Nurses (EADV) and member of the chronic illness self-management research network.

	Akira YAMASHINA Dr Akira Yamashina graduated from Hiroshima University School of Medicine in 1976. He completed his basic physician training at the St. Luke’s International Hospital Tokyo in 1980. Subsequently he took fellowship of Nuclear Cardiology at St.Luke-Roosevelt Hospital in New York. Then he returned to St. Luke’s International Hospital Tokyo as an attending staff of Cardiology. In 1999, he was asked to be the Chairman and Professor of Cardiology at Tokyo Medical University. Now he is a vice president of Tokyo Medical University Hospital. He is a member of various societies of Cardiology, Internal Medicine and Radiology and contributes as a board of trustee or consular. His main current research interests are non-invasive cardiac diagnosis such as cardiovascular imaging or evaluation of arterial function.